Forecast
The analysts' average price target is €176.01 (+7.65%). The median is €169.97 (+3.96%).
| Buy |
17 |
| Hold |
25 |
| Sell |
2 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Universal Health Services focuses on outpatient and virtual psychiatric care after Talkspace acquisition
At the Morgan Stanley Healthcare Conference, Universal Health Services announced a strategic shift toward more outpatient and digital psychiatric offerings, supported by the $835 million acquisition of Talkspace and the Thousand Branches initiative. The company trimmed its full‑year guidance by about $50 million within the range but still expects roughly 3% EBITDA growth and about 6% EPS growth. UHS sees solid acute‑care volumes, plans no major new hospital builds, intends to use AI to boost billing efficiency, and will continue share buybacks and disciplined capital allocation. » More on de.investing.com
Universal Health Services: growth stabilizes, insurance market weighs on forecast
Universal Health Services reported at the Wells Fargo conference slower but still positive growth and lowered its full-year guidance for adjusted admissions to 1.5–2.5%. The company now expects an $85 million hit from changes in the insurance market and has adjusted full-year mid‑point EBITDA down by about 3%, but still sees roughly 3% EBITDA growth year over year. UHS is expanding capacity (including 177 new beds) and bolstering outpatient psychiatry through the acquisition of Talkspace and the "Thousand Branches" initiative, but continues to face headwinds in surgical services and from market/political factors. » More on de.investing.com
S&P raises outlook for Universal Health Services to positive
S&P Global Ratings has raised the outlook for Universal Health Services from “stable” to “positive” and affirmed the issuer rating at “BB+”. For planned senior notes S&P assigned an issue rating of “BBB-” and a recovery rating of “2”. The agency sees room for an upgrade if UHS keeps leverage in the 2.0–3.0x range; the issue is intended to refinance a Sept. 2026 bond of $700m and to finance parts of the Talkspace acquisition. S&P expects slower revenue growth in 2026–2027, a slightly lower adjusted EBITDA margin in 2026, and share buybacks of about $800m in 2026 (up to $1.3bn in 2027), and sees leverage below 2.5x in 2026/2027. » More on de.investing.com
Universal Health Services cuts profit forecast — stock falls after Q2 miss
Universal Health Services reported Q2/2026 earnings per share of $5.35, missing the consensus of $5.95, although revenue of $4.64 billion was slightly above estimates. Management trimmed the full-year earnings guidance to $22.28–$23.65 and set the midpoint below the analyst consensus, after which the stock fell sharply in after-hours trading. Analyst downgrades and concerns about staffing shortages, payer mix and Medicaid risks amplified the negative market reaction and cloud the outlook for near-term margin improvement. » More on de.investing.com
Universal Health Services announces cash dividend of $0.20 per share
The board of directors of Universal Health Services has declared a cash dividend of $0.20 per share, payable on September 15, 2026, to shareholders of record as of September 1, 2026. This marks the company's 24th consecutive year of paying a dividend. The stock is trading around $148.02, close to the 52-week low of $140.08, and the dividend yield is about 0.55%. Universal Health Services operates acute-care hospitals, psychiatric facilities and outpatient care centers in the United States, Puerto Rico and the United Kingdom. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsIn 2026, Universal Health Services 'B' has already paid €0.51 in dividends. The last payout was in September.
Financials
In the last quarter, Universal Health Services 'B' had revenue of €4.18B and net profit of €272.52M
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 4.18B | 9.09% |
| Gross profit | 401.21M | 88.46% |
| Net profit | 272.52M | 14.25% |
| EBITDA | 569.47M | 3.05% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €8.04B |
Number of shares | 50.4M |
52-week high/low | €224.49 - €127.66 |
Dividend yield | 0.39% |
Dividends TTM | €0.69 |
Next dividend | €0.18 |
Beta | 1.11 |
P/E ratio | 7.26 |
PEG ratio | 0.53 |
P/B ratio | 1.35 |
P/S ratio | 0.48 |
Company profile
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
| Name | Universal Health Services 'B' |
| CEO | Marc D. Miller |
| Headquarters | King of Prussia,
pa USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| IPO | 07/09/1981 |
| Employees | 102,000 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | UHS |
London Stock Exchange | 0LJL.L |
Frankfurt | UHS.F |
Düsseldorf | UHS.DU |
London | 0LJL.L |
SIX | UHS.SW |
München | UHS.MU |